Post-market Surveillance Completed Phase Trials for Pregabalin (DB00230)

IndicationStatusPhase
DBCOND0049246 (Post-market Surveillance)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01220180Lyrica (Pregabalin) Korean Post Marketing Surveillance Study